---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-073209"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:32:14.435470+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics appoints Jennifer Fulk as CFO, succeeding retiring James Mackaness

## Summary
- Jennifer Fulk appointed CFO effective March 2, 2026; base salary $525k, target bonus 45%, option for 67,660 shares, RSUs for 39,200 shares.
- James Mackaness retiring by end of March 2026, will consult through December 2026 for smooth transition.
- Fulk brings 20+ years experience including 15 years at Eli Lilly, most recently CFO/COO at 120Water and CFO at Talkspace.
- Fulk will participate in Soleno's Key Executive Change in Control and Severance Plan.

## SEC filing metadata
- accession: 0001193125-26-073209
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/0001193125-26-073209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/d110816d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-073209
- JSON: https://secwatch.observer/filing/0001193125-26-073209.json
- Plain text: https://secwatch.observer/filing/0001193125-26-073209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.